Clinical Trial Update: Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies

View source ↗

Summary

A completed clinical trial update examining characteristics, adherence, and persistence of disease-modifying therapies in patients with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Novartis | Conditions: Multiple Sclerosis | Status: COMPLETED